Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Janin

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Drug Discovery Today|March 17, 2010
ATPase inhibitors of heat-shock protein 90, second seasonYves L Janin
RSC Medicinal Chemistry|January 29, 2024
On the origins of SARS-CoV-2 main protease inhibitorsYves L Janin
Bioorganic & Medicinal Chemistry|February 13, 2007
Antituberculosis drugs: ten years of researchYves L Janin
Beilstein Journal of Organic Chemistry|October 17, 2022
On drug discovery against infectious diseases and academic medicinal chemistry contributionsYves L Janin
Amino Acids|July 2, 2003
Peptides with anticancer use or potentialY L Janin
Occupational Medicine (Oxford, England)|November 13, 2018
Burnout, depression and paranoid ideation: a cluster-analytic studyR Bianchi, L Janin
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 25, 2010
5-Iodo-3-ethoxypyrazoles: an entry point to new chemical entitiesSandrine Guillou, Yves L Janin
Beilstein Journal of Organic Chemistry|August 12, 2022
On Reuben G. Jones synthesis of 2-hydroxypyrazinesPierre Legrand, Yves L Janin
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 26, 2015
Synthetic Routes to Coelenterazine and Other Imidazo[1,2-a]pyrazin-3-one Luciferins: Essential Tools for Bioluminescence-Based InvestigationsEloi P Coutant, Yves L Janin
La Nouvelle Presse Medicale|March 5, 1977
[Breast cancer in man]M Brunet, M L Janin, J Berlie
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Drug Discovery Today|March 17, 2010
ATPase inhibitors of heat-shock protein 90, second seasonYves L Janin
RSC Medicinal Chemistry|January 29, 2024
On the origins of SARS-CoV-2 main protease inhibitorsYves L Janin
Bioorganic & Medicinal Chemistry|February 13, 2007
Antituberculosis drugs: ten years of researchYves L Janin
Beilstein Journal of Organic Chemistry|October 17, 2022
On drug discovery against infectious diseases and academic medicinal chemistry contributionsYves L Janin
Amino Acids|July 2, 2003
Peptides with anticancer use or potentialY L Janin
Occupational Medicine (Oxford, England)|November 13, 2018
Burnout, depression and paranoid ideation: a cluster-analytic studyR Bianchi, L Janin
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 25, 2010
5-Iodo-3-ethoxypyrazoles: an entry point to new chemical entitiesSandrine Guillou, Yves L Janin
Beilstein Journal of Organic Chemistry|August 12, 2022
On Reuben G. Jones synthesis of 2-hydroxypyrazinesPierre Legrand, Yves L Janin
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 26, 2015
Synthetic Routes to Coelenterazine and Other Imidazo[1,2-a]pyrazin-3-one Luciferins: Essential Tools for Bioluminescence-Based InvestigationsEloi P Coutant, Yves L Janin
La Nouvelle Presse Medicale|March 5, 1977
[Breast cancer in man]M Brunet, M L Janin, J Berlie
Pageof 5